Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Aug;35(8):1984–1987. doi: 10.1128/jcm.35.8.1984-1987.1997

Exfoliative toxin detection using reversed passive latex agglutination: clinical and epidemiologic applications.

A Kawabata 1, S Ichiyama 1, Y Iinuma 1, Y Hasegawa 1, M Ohta 1, K Shimokata 1
PMCID: PMC229888  PMID: 9230367

Abstract

A rapid and simple method for detecting exfoliative toxin serotypes A and B from clinical isolates has been developed as a test kit (EXT-RPLA; Denka Seiken Co. Ltd., Niigata, Japan). This method is based on reversed passive latex agglutination. The detection limit of the EXT-RPLA observed for purified exfoliative toxin serotypes A and B was 1 ng/ml. We evaluated the clinical and epidemiologic uses of the EXT-RPLA. A total of 381 isolates of Staphylococcus aureus, 292 from various clinical specimens and 89 from the skin of dermatologic patients, were studied. The EXT-RPLA detected 19 exfoliative toxin producers, including 16 serotype A producers and 3 serotype B producers, but no double producers. The sensitivity and specificity of the EXT-RPLA were confirmed by the newborn mouse bioassay and a PCR assay for the structural genes for exfoliative toxin serotypes A and B (eta and etb, respectively). The overall positivity rate of exfoliative toxin producers was 5.0% (19 of 381), including 16 serotype A isolates and 3 serotype B isolates. Of the 89 isolates from the skin of dermatologic patients, 12 (13.5%) were positive for exfoliative toxin production. Only 2 (1.3%) of the 153 methicillin-resistant S. aureus isolates produced exfoliative toxin, while 17 (7.5%) of the 228 methicillin-sensitive isolates produced exfoliative toxin. The EXT-RPLA assay is a simple and reliable method for detecting exfoliative toxin, and we recommend its use for the rapid diagnosis of staphylococcal scalded skin syndrome. We also recommend its use for detection of this syndrome so that effective control measures can be taken against the spread of this syndrome.

Full Text

The Full Text of this article is available as a PDF (386.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adesiyun A. A., Lenz W., Schaal K. P. Exfoliative toxin production by Staphylococcus aureus strains isolated from animals and human beings in Nigeria. Microbiologica. 1991 Oct;14(4):357–362. [PubMed] [Google Scholar]
  2. Jackson M. P., Iandolo J. J. Cloning and expression of the exfoliative toxin B gene from Staphylococcus aureus. J Bacteriol. 1986 May;166(2):574–580. doi: 10.1128/jb.166.2.574-580.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Johnson W. M., Tyler S. D., Ewan E. P., Ashton F. E., Pollard D. R., Rozee K. R. Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction. J Clin Microbiol. 1991 Mar;29(3):426–430. doi: 10.1128/jcm.29.3.426-430.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kondo I., Sakurai S., Sarai Y., Futaki S. Two serotypes of exfoliatin and their distribution in staphylococcal strains isolated from patients with scalded skin syndrome. J Clin Microbiol. 1975 May;1(5):397–400. doi: 10.1128/jcm.1.5.397-400.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kondo I., Sakurai S., Sarai Y. New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease. Infect Immun. 1974 Oct;10(4):851–861. doi: 10.1128/iai.10.4.851-861.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lee C. Y., Schmidt J. J., Johnson-Winegar A. D., Spero L., Iandolo J. J. Sequence determination and comparison of the exfoliative toxin A and toxin B genes from Staphylococcus aureus. J Bacteriol. 1987 Sep;169(9):3904–3909. doi: 10.1128/jb.169.9.3904-3909.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Melish M. E., Glasgow L. A. Staphylococcal scalded skin syndrome: the expanded clinical syndrome. J Pediatr. 1971 Jun;78(6):958–967. doi: 10.1016/s0022-3476(71)80425-0. [DOI] [PubMed] [Google Scholar]
  8. Melish M. E., Glasgow L. A. The staphylococcal scalded-skin syndrome. N Engl J Med. 1970 May 14;282(20):1114–1119. doi: 10.1056/NEJM197005142822002. [DOI] [PubMed] [Google Scholar]
  9. Murono K., Fujita K., Yoshioka H. Detection of staphylococcal exfoliative toxin by slide latex agglutination. J Clin Microbiol. 1988 Feb;26(2):271–274. doi: 10.1128/jcm.26.2.271-274.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Murono K., Fujita K., Yoshioka H. Microbiologic characteristics of exfoliative toxin-producing Staphylococcus aureus. Pediatr Infect Dis J. 1988 May;7(5):313–315. doi: 10.1097/00006454-198805000-00003. [DOI] [PubMed] [Google Scholar]
  11. O'Reilly M., Dougan G., Foster T. J., Arbuthnott J. P. Plasmids in epidermolytic strains of Staphylococcus aureus. J Gen Microbiol. 1981 May;124(1):99–107. doi: 10.1099/00221287-124-1-99. [DOI] [PubMed] [Google Scholar]
  12. Piemont Y., Rasoamananjara D., Fouace J. M., Bruce T. Epidemiological investigation of exfoliative toxin-producing Staphylococcus aureus strains in hospitalized patients. J Clin Microbiol. 1984 Mar;19(3):417–420. doi: 10.1128/jcm.19.3.417-420.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Piémont Y., Haubensack M., Monteil H. Enzyme-linked immunosorbent assays for Staphylococcus aureus exfoliative toxins A and B and some applications. J Clin Microbiol. 1984 Dec;20(6):1114–1121. doi: 10.1128/jcm.20.6.1114-1121.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Richardson J. F., Quoraishi A. H., Francis B. J., Marples R. R. Beta-lactamase-negative, methicillin-resistant Staphylococcus aureus in a newborn nursery: report of an outbreak and laboratory investigations. J Hosp Infect. 1990 Aug;16(2):109–121. doi: 10.1016/0195-6701(90)90055-s. [DOI] [PubMed] [Google Scholar]
  15. Rifai S., Barbancon V., Prevost G., Piemont Y. Synthetic exfoliative toxin A and B DNA probes for detection of toxigenic Staphylococcus aureus strains. J Clin Microbiol. 1989 Mar;27(3):504–506. doi: 10.1128/jcm.27.3.504-506.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rogolsky M., Warren R., Wiley B. B., Nakamura H. T., Glasgow L. A. Nature of the genetic determinant controlling exfoliative toxin production in Staphylococcus aureus. J Bacteriol. 1974 Jan;117(1):157–165. doi: 10.1128/jb.117.1.157-165.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sakurai S., Suzuki H., Machida K. Rapid identification by polymerase chain reaction of staphylococcal exfoliative toxin serotype A and B genes. Microbiol Immunol. 1995;39(6):379–386. doi: 10.1111/j.1348-0421.1995.tb02216.x. [DOI] [PubMed] [Google Scholar]
  18. Sarai Y., Nakahara H., Ishikawa T., Kondo I., Futaki S. Detection of anti-exfoliatin antibodies in healthy adults and children by the passive hemagglutination test. Infect Immun. 1977 Jun;16(3):1024–1026. doi: 10.1128/iai.16.3.1024-1026.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Warren R., Rogolsky M., Wiley B. B., Glasgow L. A. Effect of ethidium bromide on elimination of exfoliative toxin and bacteriocin production in Staphylococcus aureus. J Bacteriol. 1974 Jun;118(3):980–985. doi: 10.1128/jb.118.3.980-985.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Warren R., Rogolsky M., Wiley B. B., Glasgow L. A. Isolation of extrachromosomal deoxyribonucleic acid for exfoliative toxin production from phage group II Staphylococcus aureus. J Bacteriol. 1975 Apr;122(1):99–105. doi: 10.1128/jb.122.1.99-105.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wiley B. B., Rogolsky M. Molecular and serological differentiation of staphylococcal exfoliative toxin synthesized under chromosomal and plasmid control. Infect Immun. 1977 Nov;18(2):487–494. doi: 10.1128/iai.18.2.487-494.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wuepper K. D., Baker D. H., Dimond R. L. Measurement of the staphylococcal epidermolytic toxin: a comparison of bioassay, radial immunodiffusion, and radioimmunoassay. J Invest Dermatol. 1976 Oct;67(4):526–531. doi: 10.1111/1523-1747.ep12664548. [DOI] [PubMed] [Google Scholar]
  23. de Azavedo J. C., Arbuthnott J. P. Assays for epidermolytic toxin of Staphylococcus aureus. Methods Enzymol. 1988;165:333–338. doi: 10.1016/s0076-6879(88)65049-x. [DOI] [PubMed] [Google Scholar]
  24. de Azavedo J., Arbuthnott J. P. Prevalence of epidermolytic toxin in clinical isolates of Staphylococcus aureus. J Med Microbiol. 1981 Aug;14(3):341–344. doi: 10.1099/00222615-14-3-341. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES